Compare EOLS & BBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EOLS | BBCP |
|---|---|---|
| Founded | 2012 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Engineering & Construction |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 500.0M | 529.1M |
| IPO Year | 2018 | 2017 |
| Metric | EOLS | BBCP |
|---|---|---|
| Price | $6.96 | $10.11 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $15.40 | $13.50 |
| AVG Volume (30 Days) | ★ 773.5K | 101.7K |
| Earning Date | 11-04-2026 | 09-03-2026 |
| Dividend Yield | N/A | ★ 5.06% |
| EPS Growth | ★ 1.23 | N/A |
| EPS | N/A | ★ 0.07 |
| Revenue | $297,176,000.00 | ★ $392,867,000.00 |
| Revenue This Year | $12.48 | $9.73 |
| Revenue Next Year | $16.86 | $5.12 |
| P/E Ratio | ★ N/A | $145.93 |
| Revenue Growth | ★ 11.61 | N/A |
| 52 Week Low | $3.86 | $5.56 |
| 52 Week High | $9.31 | $12.19 |
| Indicator | EOLS | BBCP |
|---|---|---|
| Relative Strength Index (RSI) | 44.36 | 55.19 |
| Support Level | $6.42 | $9.41 |
| Resistance Level | $7.07 | $10.94 |
| Average True Range (ATR) | 0.40 | 0.42 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 39.70 | 53.91 |
Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.
Concrete Pumping Holdings Inc is a provider of concrete pumping services and concrete waste management services in the fragmented United States and United Kingdom markets. Its large fleet of specialized pumping equipment and trained operators enables it to deliver concrete placement solutions. The company's operating segments include U.S. Concrete Pumping, U.K. Operations, and U.S. Concrete Waste Management Services, with the majority of revenue generated from the U.S. Concrete Pumping segment. Geographically, it operates in the United States and the United Kingdom, generating majority of its revenue from the United States.